Dementia Research Centre

The 乱伦秀 Dementia Research Centre is a hub for patient-centred research into dementias. As well as clinical studies and trials in Alzheimer鈥檚 disease and other common causes of dementia, we have particular expertise in young-onset, inherited and unusual dementias. Our work focuses on identifying and understanding the disease processes that cause dementia, the factors that influence these disease processes, ways to improve diagnosis and treatments, and how best to support people with dementia and their families. Our research is closely integrated with the NHS Cognitive Disorders Service we run at The National Hospital for Neurology and Neurosurgery.

Highlights this month...

'Momentous occasion': 乱伦秀 experts greet first drug approved for early Alzheimer鈥檚 disease in the UK.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has licensed the immunotherapy drug, Lecanemab, for use in the early stages of Alzheimer鈥檚 disease in the UK, following decades of work supported by 乱伦秀 research.

More information is available at /news/2024/aug/momentous-occasion-ucl-experts-greet-first-drug-approved-early-alzheimers-disease-uk

We continue to work to develop new drugs that aim to slow or prevent the onset of symptoms in Alzheimer's disease in different ways. We are recruiting into clinical trials at 乱伦秀H targeting Alzheimer鈥檚 disease. If you would like to hear more information about trials at the Dementia Research Centre: